Sudeep Pharma Ltd

BSE: 544619

total announcements

544619.BO · 15 min delayed

BSECompany UpdateRegulatory8h ago

Sudeep Pharma Ltd

The Exchange has received the disclosure under Regulation 29(1) & 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Nuvama Crossover Opportunities Fund ....

Sudeep Pharma Ltd has received a disclosure under SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 from Nuvama Crossover Opportunities Fund regarding a potential acquisition of shares.

Intimation for Earnings call to be held on Wednesday, 5th August 2026

Sudeep Pharma Ltd schedules earnings call with analysts/investors on August 5, 2026, to discuss Q1FY27 financial results.

Sudeep Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/08/2026 ,inter alia, to consider and approve the unaudited financials (standalone ....

Sudeep Pharma Ltd has scheduled a board meeting on 4th August 2026 to consider and approve the unaudited financials for the quarter ended 30th June 2026.